Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
CooperSurgical has acquired Embryo Options, offering cryo-storage software solutions for clinics and patients.
read more
Friday, November 15, 2013
ordenPharma acquired Ancora Pharmaceuticals, located in Woburn, MA, USA. Ancora’s unique carbohydrate synthesis technology platform and chemistry research facilities perfectly complement CordenPharma’s capabilities in the manufacture and supply of ...
read more
Wednesday, October 11, 2017
CordenPharma has entered into definite agreements to acquire the former Hospira Boulder (Colorado) high containment API site from Pfizer.
read more
CordenPharma International and pHLIP, Inc. announced a strategic alliance to collaborate in developing and commercializing the pHLIP-LNP targeted delivery platform for RNA-based and genetic therapeutics.
read more
Wednesday, March 12, 2025
CordenPharma announced the signing of a strategic partnership with Viking Therapeutics, Inc., a clinical-stage company focused on developing novel therapies for metabolic and endocrine disorders. Under this multi-year supply contract, CordenPharma ...
read more
CordenPharma Group announced the appointment of Dr. Michael Quirmbach as Chief Executive Officer & President, effective August 1, 2019.
read more
Agilent Technologies announced that it is breaking ground on a 15,000-square-foot expansion of the company’s logistics center in Cedar Creek, Texas.
read more
CordenPharma announces a strategic investment of €3.7 million in the manufacturing site infrastructure of its CordenPharma Switzerland facility, located in Liestal, Switzerland.
read more
CordenPharma has agreed to acquire AmbioPharm, a U.S.-headquartered peptide active pharmaceutical ingredient (API) contract development and manufacturing organization.
read more
Thursday, February 03, 2022
CordenPharma has announced the completion of the acquisition of three manufacturing facilities from Vifor Pharma, to be ultimately renamed Corden Pharma Fribourg S.A. (including its Ettingen branch) in Switzerland, and Corden Pharma Lisbon S.A. in ...
read more
CordenPharma, a Contract Development and Manufacturing Organization (CDMO), created a new Technology & Science Advisory Board (TSAB) with eight world-class experts from academia and industry, who will provide strategic guidance and scientific ...
read more
Wednesday, March 06, 2024
CordenPharma has announced the commissioning of new GMP capacities at Frankfurt to manufacture early clinical phase peptide APIs for pharma and biotech customers. The investment, which is still being finalized, will be fully operational in Q2 2024 ...
read more
CordenPharma announced a >€1 billion strategic investment in peptide development and manufacturing.
read more
Friday, September 15, 2023
CordenPharma announced the inauguration of increased commercial peptide production capacity with newly-upgraded facilities at CordenPharma Colorado, the largest Solid-Phase Peptide Synthesis (SPPS) Manufacturing facility worldwide.
read more
CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its Peptide technology platform.
read more